Question 1

What is LOPJLB’s current signal on SPRY?

Accepted Answer

LOPJLB’s latest quantitative signal on ARS Pharmaceuticals, Inc. (SPRY) is SELL in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is SPRY in?

Accepted Answer

ARS Pharmaceuticals, Inc. (SPRY) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does ARS Pharmaceuticals, Inc. (SPRY) do?

Accepted Answer

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intran…

Question 4

Where is ARS Pharmaceuticals, Inc. based / listed?

Accepted Answer

ARS Pharmaceuticals, Inc. is based in US, listed on NASDAQ.

ARS Pharmaceuticals, Inc. (SPRY)

Key stats

Industry peers

Prediction markets

ANALYST & RATINGS

Company news